Literature DB >> 6405439

Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system.

C Spyraki, H C Fibiger, A G Phillips.   

Abstract

The rewarding properties of systemically administered heroin were investigated with a conditioned place-preference paradigm. Reinforcing effects were observed with all doses of heroin tested (0.5, 1.0, 2.0 mg/kg) as indicated by a significant increase in preference for the place paired with drug injections. No similar change in preference was observed following saline injections. The rewarding effect of heroin (2 mg/kg) was attenuated by pretreatment with haloperidol (0.2 mg/kg), but haloperidol alone did not produce a place aversion. Lesions induced by 6-hydroxydopamine (6-OHDA) of the mesolimbic dopaminergic pathway at the level of the nucleus accumbens also attenuated the heroin-induced place preference. In contrast, depletion of central and peripheral noradrenaline induced by 6-OHDA had no significant effect on heroin-induced place preference. These data suggest an important role for the mesolimbic DA system in mediating the reinforcing effects of heroin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405439     DOI: 10.1007/BF00427827

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

Review 1.  Catecholamine theories of reward: a critical review.

Authors:  R A Wise
Journal:  Brain Res       Date:  1978-08-25       Impact factor: 3.252

2.  Stereotaxic mapping of the monoamine pathways in the rat brain.

Authors:  U Ungerstedt
Journal:  Acta Physiol Scand Suppl       Date:  1971

3.  Depression of morphine-seeking behaviour by dopamine inhibition.

Authors:  A S Schwartz; P L Marchok
Journal:  Nature       Date:  1974-03-15       Impact factor: 49.962

4.  Specific noradrenergic neurones destroyed by 6-hydroxydopamine injection into newborn rats.

Authors:  K M Taylor; D W Clark; R Laverty; E L Phelan
Journal:  Nat New Biol       Date:  1972-10-25

5.  Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.

Authors:  A G Phillips; F G LePiane
Journal:  Behav Brain Res       Date:  1982-06       Impact factor: 3.332

6.  Reinforcing effects of brain microinjections of morphine revealed by conditioned place preference.

Authors:  D van der Kooy; R F Mucha; M O'Shaughnessy; P Bucenieks
Journal:  Brain Res       Date:  1982-07-08       Impact factor: 3.252

7.  Rewarding and aversive effects of morphine: temporal and pharmacological properties.

Authors:  J E Sherman; C Pickman; A Rice; J C Liebeskind; E W Holman
Journal:  Pharmacol Biochem Behav       Date:  1980-10       Impact factor: 3.533

8.  Morphine suppression of substantia nigra zona reticulata neurons in the rat: implicated role for a novel striatonigral feedback mechanism.

Authors:  E P Finnerty; S H Chan
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

9.  Dopaminergic and cholinergic influences on morphine self-administration in rats.

Authors:  S D Glick; R D Cox
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-09

10.  6-OHDA lesion to the dorsal noradrenergic bundle alters morphine-induced locomotor activity and catalepsy.

Authors:  D C Roberts; S T Mason; H C Fibiger
Journal:  Eur J Pharmacol       Date:  1978-11-15       Impact factor: 4.432

View more
  54 in total

1.  Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway.

Authors:  R Spanagel; A Herz; T S Shippenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Comparative effects of preoptic area infusions of opioid peptides, lesions and castration on sexual behaviour in male rats: studies of instrumental behaviour, conditioned place preference and partner preference.

Authors:  A M Hughes; B J Everitt; J Herbert
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.

Authors:  Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

4.  The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity.

Authors:  S Mithani; M T Martin-Iverson; A G Phillips; H C Fibiger
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Effects of dopaminergic agents on alcohol consumption by rats in a limited access paradigm.

Authors:  M A Linseman
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats.

Authors:  A Guyon; F Assouly-Besse; G Biala; A J Puech; M H Thiébot
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

8.  Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats.

Authors:  N Joharchi; E M Sellers; G A Higgins
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

10.  Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats.

Authors:  H O Pettit; A Ettenberg; F E Bloom; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.